CUE
Cue Biopharma
NASDAQ: CUE · HEALTHCARE · BIOTECHNOLOGY
$14.74
+13.38% today
Updated 2026-04-30
Market cap
$57.60M
P/E ratio
—
P/S ratio
2.10x
EPS (TTM)
$-8.40
Dividend yield
—
52W range
$5 – $31
Volume
11.4M
Cue Biopharma (CUE) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $1.14M | $3.46M | $3.15M | $14.94M | $1.25M | $5.49M | $9.29M | $27.47M |
| Revenue growth (YoY) | — | — | — | — | +202.6% | -8.8% | +373.7% | -91.7% | +341.0% | +69.2% | +195.7% |
| Cost of revenue | $44815.00 | $202085.00 | $419568.00 | $28.54M | $27.49M | $33.55M | $-1.78M | $1.81M | $38.10M | $2.35M | $3.48M |
| Gross profit | $-44815.00 | $-202085.00 | $-419568.00 | $-27.40M | $3.46M | $-30.39M | $14.94M | $1.25M | $-32.61M | $9.29M | $23.99M |
| Gross margin | — | — | — | -2398.2% | 100.0% | -963.5% | 100.0% | 100.0% | -593.9% | 100.0% | 87.3% |
| R&D | $1.50M | $5.69M | $18.90M | $28.54M | $27.49M | $33.55M | $41.35M | $38.58M | $40.80M | $36.30M | $37.74M |
| SG&A | $425081.00 | $1.97M | $4.33M | $11.30M | $12.74M | $14.65M | $17.31M | $16.17M | $16.68M | $14.59M | $16.24M |
| Operating income | $-1.93M | $-7.66M | $-23.23M | $-38.70M | $-36.77M | $-45.04M | $-43.71M | $-53.23M | $-52.15M | $-41.50M | $-26.55M |
| Operating margin | — | — | — | -3386.7% | -1063.3% | -1428.0% | -292.6% | -4275.1% | -949.9% | -446.9% | -96.7% |
| EBITDA | $-1.88M | $-7.46M | $-22.81M | $-37.94M | $-31.60M | $-43.99M | $-45.49M | $-50.49M | $-46.05M | $-37.53M | $-23.04M |
| EBITDA margin | — | — | — | -3320.2% | -913.9% | -1394.4% | -304.5% | -4055.5% | -838.8% | -404.1% | -83.9% |
| EBIT | $-1.93M | $-7.66M | $-23.23M | $-38.70M | $-36.77M | $-45.04M | $-43.71M | $-52.30M | $-49.49M | $-39.88M | $-26.52M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $5.65M | $463914.00 | $1.73M | $713815.00 | $1.25M | $796000.00 | $357000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-1.93M | $-7.66M | $-23.23M | $-38.98M | $-36.70M | $-44.78M | $-44.16M | $-53.01M | $-50.73M | $-40.67M | $-26.60M |
| Net income growth (YoY) | — | -297.1% | -203.4% | -67.8% | +5.9% | -22.0% | +1.4% | -20.0% | +4.3% | +19.8% | +34.6% |
| Profit margin | — | — | — | -3411.5% | -1061.2% | -1419.8% | -295.6% | -4257.8% | -924.1% | -438.0% | -96.9% |